Wells Fargo & Company Kiromic Biopharma, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.16 - $11.77 $0 - $23	2 Added 2.67%	77 $0
Q3 2022 Nov 14, 2022	BUY	$0.26 - $10.2 $8 - $336	33 Added 78.57%	75 $0
Q2 2022 Aug 12, 2022	BUY	$0.26 - $0.87 $1 - $3	4 Added 10.53%	42 $0
Q3 2021 Nov 15, 2021	BUY	$2.69 - $4.94 $80 - $148	30 Added 375.0%	38 $0
Q4 2020 Feb 09, 2021	BUY	$8.11 - $11.5 $64 - $92	8 New	8 $0

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.